Wed, May 15, 2024

Andrew Fein Reiterated (UBX) at Strong Buy and Held Target at $8 on, May 15th, 2024

Andrew Fein of HC Wainwright & Co., Reiterated "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $8 on, May 15th, 2024.

Andrew, nor any peers, have made any analyst calls on UBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30